KLARITOS Develops Assurance-Based Managed Care Model to Address Critical Inefficiencies in Specialty Drug Spending
By a
Specialty drugs are expensive. The list prices are ca.
"We have developed a proprietary managed care platform to address these inefficiencies. The K360TM platform adopts precision medicine approach on a disease-specific basis. It provides continued touchpoints between approved drugs and patients-from the selection of right therapies from its formulary and prior authorization to continued treatment guidance," said
"We have developed a proprietary assurance product, KlariPayTM, which provides a priori therapeutic efficacy and financial assurances to our customers-employers and independent payers. Depending on the disease indications, the financial assurance may involve either full or partial limited money-back guarantee," said Ramakrishnan. "We are actively building our drug formulary and establishing partnerships with employers and payers. We expect to be market-ready in early 2020."
Some of the distinct features of the model are: K360 is an integrated platform that consists of a novel treatment paradigm and efficient drug distribution and payment system;
a multi-sided platform with market-making capabilities, connecting multiple users: employers, payers, and patients on the one end, and pharma and diagnostic companies on the other end; Klari-PDPTM: Disease-specific prescription drug plan; the drug formulary will carry specialty drugs for which clear efficacy correlations are observed in stratified subsets of patients; Integrated treatment system-comprised of prior authorization, continued theragnostic guidance, and disease & therapy management; and Product differentiation features for the drugs included in its formulary.
Keywords for this news article include: KLARITOS, Managed Care, Health and Medicine, Investment and Finance.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
Reports Outline Psoriasis Study Results from Sungkyunkwan University (Healthcare utilization and medical expenditure of Korean psoriasis patients: A…
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News